Human interleukin-4 receptor alpha antibodies
US11891441B2 · kind B2 · utility
0Cited by
0References
69Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 5, 2022 |
| Grant date | Feb 6, 2024 |
| Priority date | — |
| Expiry date | Aug 5, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2015/8518
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present disclosure relates to antibodies that specifically bind human IL-4Rα, compositions comprising such IL-4Rα antibodies, and methods of using such IL-4Rα antibodies.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.